GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Net Margin (2009 - 2026)

Updated

Gsk (GSK) reported Net Margin of 17.36% for the quarter ended Sep 30, 2026, down 6.19 percentage points from 23.55% a year earlier but up 12.19 percentage points from the prior quarter.

Analysis

Gsk (GSK) Net Margin (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Gsk's Net Margin came in at 16.37%, down 0.78 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 17.50%, up 9.29 percentage points from the prior year.

  • Net Margin has a five-year change of -6.11 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, Net Margin came in at 8.21% in the year ended Dec 31, 2024 (-8.04 pp), 16.25% in the year ended Dec 31, 2023 (-34.75 pp), 51.00% in the year ended Dec 31, 2022 (+33.25 pp) and 17.76% in the year ended Dec 31, 2021 (-5.85 pp).
  • Five-year quarterly Net Margin spans a low of -0.72% in the quarter ended Sep 30, 2024 and a high of 138.22% in the quarter ended Sep 30, 2022.
  • Year over year, Net Margin gained in six of the last eight quarters, with an average year-over-year change of +3.76 percentage points.
  • The high point for year-over-year Net Margin in five years was the quarter ended Sep 30, 2022 (a gain of 120.59 percentage points); the low point was the quarter ended Sep 30, 2023 (a drop of 120.25 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at 5.17% (quarter ended Jun 30, 2026), 22.77% (quarter ended Mar 31, 2026) and 17.50% (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn 0.83%
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 21.27%
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn 16.30%
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 23.62%
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn -1.65%
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn 17.36%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.36%
Jun 30, 2026 5.17%
Mar 31, 2026 22.77%
Dec 31, 2025 17.50%
Sep 30, 2025 23.55%
Jun 30, 2025 18.07%
Mar 31, 2025 21.61%
Dec 31, 2024 5.10%
Sep 30, 2024 -0.72%
Jun 30, 2024 14.88%
Mar 31, 2024 14.21%
Dec 31, 2023 4.35%
Sep 30, 2023 17.97%
Jun 30, 2023 22.62%
Mar 31, 2023 21.44%
Dec 31, 2022 20.27%
Sep 30, 2022 138.22%
Jun 30, 2022 12.09%
Mar 31, 2022 25.06%
Dec 31, 2021 10.59%
API Access

Gsk Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY